AMCI vs REGN · rev $6.0M vs P/E 14, rev $4.29B
AMC Robotics Corporation (AMCI) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
AMC Robotics Corporation (AMCI) is a computer hardware company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported AMCI revenue for 2025-12-31 was $6.0M. Net income was -$24.8M. Revenue was down 41.4% from 2024-12-31 to 2025-12-31. AMCI currently screens at market cap $100.3M.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
AMCI currently screens at market cap $100.3M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the AMCI and REGN stock pages for the full models.
Not investment advice.